Neuroinflammation appeared to be modest at the early stages of AD pathogenesis, with only the astrocyte marker Ccl3 (alias MIP1-α) gene expressed at higher levels in APP/PS1 mice compared to WT mice. The gene discussed is CCL3; the disease is Alzheimer disease.